Double Filtration Plasmapheresis Treatment of Refractory Multiple Sclerosis Relapsed on Fingolimod: A Case Report
Double filtration plasmapheresis (DFPP) is an emerging semi-selective apheretic method for treating immuno-mediated neurological diseases. Here we report the first case of steroid-refractory relapsed multiple sclerosis (MS) on Fingolimod (FTY), treated effectively by this technique, in a 37-year-old...
Main Authors: | Roberto De Masi, Stefania Orlando, Salvatore Accoto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/10/21/7404 |
Similar Items
-
Role of double-filtration plasmapheresis in ABO- and human leukocyte antigen-incompatible kidney transplant
by: Smriti Sinha, et al.
Published: (2022-01-01) -
FEATURES OF PLASMAPHERESIS IN THE TREATMENT OF GRAFT REJECTION AFTER KIDNEY TRANSPLANTATION
by: A. V. Vatazin, et al.
Published: (2015-10-01) -
Double Filtration Plasmapheresis in the Treatment of a Case with Acute Disseminated Encephalomyelitis
by: Mehmet Uğur Çevik, et al.
Published: (2013-06-01) -
Bacteremia in autoimmune bullous disease patients undergoing double-filtration plasmapheresis
by: Chika Ohata, et al.
Published: (2019-05-01) -
Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis
by: Burcu Altunrende, et al.
Published: (2017-12-01)